Failure of P strain mice to respond to vaccination against schistosomiasis correlates with impaired production of IL-12 and up-regulation of Th2 cytokines that inhibit macrophage activation

European Journal of Immunology

Volumn 28, Issue 6, 1998, Pages 1762-1772

  Oswald, Isabelle P ^a,b,c   Caspar, Patricia ^a   Wynn, Thomas A ^a   Scharton Kersten, Tanya ^a   Williams, Megan E ^a   Hieny, Sara ^a   Sher, Alan ^a   James, Stephanie L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CEMAGREF   (France)

^c Lab de Pharmacologie Toxicologie   (France)

Author keywords

Cytokine; IL 12; Macrophage; Monocyte; Schistosome; Vaccination

Indexed keywords

ANTIGEN; BCG VACCINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; SCHISTOSOMA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CERCARIA; CONTROLLED STUDY; HELPER CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION ATTENUATION; SCHISTOSOMIASIS; SPLEEN CELL; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOMPHALARIA; CELL LINE; CYTOKINES; FEMALE; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C57BL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLEEN; TH1 CELLS; TH2 CELLS; UP-REGULATION; VACCINATION;

EID: 0031813898     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199806)28:06<1762::AID-IMMU1762>3.0.CO;2-J     Document Type: Article

References (37)

1. The control of schistosomiasis. In Second Report of the WHO Expert Committee, World Health Organization, Geneva 1993.
2. Bergquist, N. R., Hall, B. F. and James, S. L., Schistosomiasis vaccine development: translating basic research into practical results. Immunologist 1994. 2: 131.
3. James, S. L. and Boros, D. L., Immune effector role of macrophages in experimental schistosomiasis mansoni. Immunol. Ser. 1994. 60: 461-473.
4. Smythies, L. E., Coulson, P. S. and Wilson, R. A., Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J. Immunol. 1992. 149: 3654-3658.
5. Wynn, T. A., Oswald, I. P., Eltoum, I. A., Caspar, P., Lowenstein, C., Lewis, F. A., James, S. L. and Sher, A., Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 1994. 153: 5200-5209.
6. James, S. L., Correa-Oliveira, R., Sher, A., Medvitz, L. and McCall, R. D., Genetic association of defects in macrophage larvicidal activity and vaccine-induced resistance to Schistosoma mansoni in P strain mice. Infect. Immun. 1987. 55: 1884-1889.
7. Snippe, H., Johnannesen, L., Lizzio, E. and Merchant, B., Variable expression of delayed hypersensitivity in different mouse strains using dimethyl dioctadecyl ammonium bromide as an adjuvant. Immunology 1980. 39: 399-405.
8. Boraschi, D. and Meltzer, S., Defective tumoricidal capacity of macrophages from P mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness. J. Immunol. 1990. 125: 777-782.
9. Nacy, C. A., Meltzer, M. S. and Fortier, A. H., Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine induced antimicrobial activities against Leishmania tropica amastigotes. J. Immunol. 1984. 133: 3344-3350.
10. James, S. L., Correa-Oliveira, R. and Leonard, E. J., Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular response. J. Immunol. 1984. 133: 1587-1693.
11. James, S. L., Deblois, L., Al-Zamel, F., Glaven, J. and Langhorne, J., Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. III. Specificity of the associated defect in cell-mediated immunity. J. Immunol. 1986. 137: 3959-3967.
12. James, S. L., Salzman, C. and Pearce, E. J., Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. VI. Antigen recognition by nonresponder mouse strains. Parasite Immunol. 1988. 10: 71-83.
13. Oswald, I. P., Gazzinelli, R. T., Sher, A. and James, S. L., IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J. Immunol. 1992. 148: 3578-3582.
14. James, S. L., Natovitz, P. C., Farrar, W. L. and Leonard, E. J., Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation attenuated cercariae. Infect. Immun. 1984. 44: 569-575.
15. James, S. L., Induction of protective immunity against Schistosoma mansoni by a non living vaccine. III. Correlation of resistance with induction of activated larvicidal macrophages. J. Immunol. 1986. 36: 3872-3877.
16. Oswald, I. P., Wynn, T. A., Sher, A. and James, S. L., IL-10 inhibits macrophage microbicidal activity by blocking the endogenous production of TNF-α required as a co-stimulatory factor for IFN-γ induced activation. Proc. Natl. Acad. Sci. USA 1992. 89: 8676-8680.
17. Williams, M. A., Caspar, P., Oswald, I. P., Sharma, H. K., Pankewycz, O., Sher, A. and James, S. L., Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-β which down-regulates macrophage antiparasitic activity. J. Immunol. 1995. 154: 4693-4700.
18. Oswald, I. P., Caspar, P., Jankovic, D., Wynn, T. A., Pearce, E. J. and Sher, A., Interleukin 12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J. Immunol. 1994. 153: 1707-1713.
19. Trinchieri, G. and Scott, P., Immunoregulation by Interleukin-12. Res. Immunol. 1995. 146: 423-431.
20. Murray, H. W., Spitalny, G. L. and Nathan, C. F., Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-γ. J. Immunol. 1985. 134: 1619-1622.
21. James, S. L., Role of nitric oxide in parasitic infections. Microbiol. Rev. 1995. 59: 533-547.
22. Bogdan, C. and Nathan, C., Modulation of macrophages function by transforming growth factor β, interleukin-4 and interleukin-10. Ann. N.Y. Acad. Sci. 1993. 685: 713-739.
23. Guler, M. L., Jacobson, N. G., Gubler, U. and Murphy, K. M., T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. J. Immunol. 1997. 159: 1767-1774.
24. Szabo, S. J., Dighe, A. S., Gubler, U. and Murphy, K. M., Regulation of interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 1997. 185: 817-824.
25. D'Andrea, A., Aste-Amezaga, M., Vaiante, M. N., Ma, X., Kubin, M. and Trinchieri, G., Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 1993. 178: 1041-1048.
26. Manetti, R., Parronchi, P., Giudizi, M. G., Piccini, M. P., Maggi, E., Trinchieri, G. and Romagnani, S., Natural killer cell stimulatory factor (NKSF/IL-12) induces Th1-type specific immune responses and inhibits the development of IL-4 producing Th2 cells. J. Exp. Med. 1993. 177: 1199-1204.
27. Wynn, T. A., Cheever, A. W., Jankovic, D., Poindexter, R. P., Caspar, P., Lewis, F. and Sher, A., An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995. 376: 594-596.
28. Ladzins, J. R., Stein, M. J., David, J. R. and Sher, A., Schistosoma mansoni: a rapid isolation and purification of schistosomula of different developmental stage by centrifugation on discontinuous density gradients of Percoll. Exp. Parasitol. 1982. 53: 39-44.
29. Pearce, E. J., James, S. L., Heiny, S., Lanar, D. E. and Sher, A., Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a non surface parasite antigen. Proc. Natl. Acad. Sci. USA 1988. 85: 5678-5682.
30. Minard, P., Dean, D. A., Jacobson, R. H., Vannier, W. E. and Murrell, K. D., Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercaria. Am. J. Trop. Med. Hyg. 1978. 26: 76-86.
31. James, S. L., Pearce, E. J. and Sher, A., Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts. J. Immunol. 1985. 134: 3432-3438.
32. Mosmann, T. R., Schumaker, J. H., Fiorentino, D. F., Leverah, H., Moore, K. W. and Bond, M. W., Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6 and a new Th2 specific cytokine, cytokine synthesis inhibitory factor (CSIF, IL-10) using a solid phase radioimmunosorbent assay. J. Immunol. 1990. 145: 2938-2945.
33. Ohara, J. and Paul, W. E., Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 1985. 315: 333-336.
34. James, S. L., Parasiticidal activity of macrophages against schistosomes. Methods Enzymol. 1986. 132: 649-658.
35. Mosmann, T. R. and Fong, T. A. T., Specific assays for cytokine production by T cells. J. Immunol. Methods 1989. 116: 151-158.
36. Vieira, L. Q., Hondowicz, B. D., Afonso, L. C. C., Wysocka, M., Trinchieri G. and Scott, P., Infection with Leishmania major induces interleukin 12 in vivo. Immunol. Lett. 1994. 40: 157-161.
37. Hu-Li, J., Ohara, J., Watson, C., Tsang, W. and Paul, W. E., Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an hyporesponsive mutant of that line (CT.4S). J. Immunol. 1989. 142: 800-807.